Recent News for STRO - Sutro Biopharma, Inc.

Date Title
Nov 30 Stocks To Watch: ViacomCBS, Amazon's AWS Event And Conference Blitz
Nov 19 Sutro Biopharma to Present at the Stifel 2019 Healthcare Conference
Nov 8 Sutro Biopharma, Inc. (STRO): Hedge Funds Are Snapping Up
Nov 8 Sutro Biopharma EPS beats by $0.09, beats on revenue
Nov 8 Sutro Biopharma Reports Third Quarter 2019 Financial Results and Recent Business Highlights and Developments
Oct 30 Introducing Sutro Biopharma (NASDAQ:STRO), The Stock That Dropped 15% In The Last Year
Oct 29 The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study
Oct 29 Sutro Biopharma Presents Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002 Antibody-Drug Conjugate in Patients with Advanced Ovarian Cancer
Oct 27 The Week Ahead In Biotech: Adcom Test For Agile; Pfizer, Merck Lead Earnings
Oct 18 Key events next week - healthcare
Oct 16 Sutro Biopharma Announces Presentation of STRO-002 for the Potential Treatment of Ovarian and Endometrial Cancer at the 2019 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference
Oct 8 Sutro Biopharma to Receive Milestone Payment for Novel Bispecific Antibody Drug Conjugate Targeting Solid Tumors
Oct 7 Healthcare dominate midday movers
Oct 7 Sutro Bio up 22% after mixed shelf filing
Oct 7 Sell-siders waving pom-poms on SmileDirectClub in premarket analyst action
Oct 7 4 Stocks To Watch For October 7, 2019
Sep 5 Oppenheimer likes Incyte in premarket analyst action
Sep 4 Sutro Biopharma to Present at the H.C. Wainwright 21st Annual Healthcare Conference
Sep 3 Targeting flesh-eating, drug-resistant bacteria, Peninsula company grabs small grant for antibiotic
Aug 14 Sutro Biopharma EPS beats by $0.02, beats on revenue
Aug 14 Sutro Biopharma Reports Second Quarter 2019 Financial Results and Recent Business Highlights and Developments
Aug 8 Sutro Biopharma to Present at the 2019 Wedbush PacGrow Healthcare Conference
Jul 31 Is Sutro Biopharma (NASDAQ:STRO) Using Debt In A Risky Way?
Jul 18 Wainwright sees 310% upside in Outlook Therapeutics in premarket analyst action
Jul 4 Here’s What Hedge Funds Think About Sutro Biopharma, Inc. (STRO)

Back to the Main STRO Page...